Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Jacobs Solutions Inc. (NYSE:J – Get Rating) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 2,389 shares of the company’s stock, valued at approximately $304,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Mackenzie Financial Corp increased its stake in shares of Jacobs Solutions by 1,162.8% in the 1st quarter. Mackenzie Financial Corp now owns 866,765 shares of the company’s stock worth $119,449,000 after acquiring an additional 798,125 shares in the last quarter. Select Equity Group L.P. increased its stake in shares of Jacobs Solutions by 12.4% in the 1st quarter. Select Equity Group L.P. now owns 5,814,904 shares of the company’s stock worth $801,352,000 after acquiring an additional 641,965 shares in the last quarter. Findlay Park Partners LLP increased its stake in shares of Jacobs Solutions by 31.8% in the 1st quarter. Findlay Park Partners LLP now owns 2,439,437 shares of the company’s stock worth $336,179,000 after acquiring an additional 589,091 shares in the last quarter. Iat Reinsurance Co. LTD. bought a new position in shares of Jacobs Solutions in the 1st quarter worth about $58,590,000. Finally, Invesco Ltd. increased its stake in shares of Jacobs Solutions by 44.6% in the 1st quarter. Invesco Ltd. now owns 1,291,182 shares of the company’s stock worth $177,937,000 after acquiring an additional 398,033 shares in the last quarter. 86.73% of the stock is owned by hedge funds and other institutional investors.
Jacobs Solutions Stock Performance
J opened at $125.72 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 0.59. The company has a market cap of $16.04 billion, a price-to-earnings ratio of 35.31, a PEG ratio of 1.45 and a beta of 0.88. The company’s 50 day moving average is $115.73 and its 200 day moving average is $125.59. Jacobs Solutions Inc. has a 12-month low of $106.78 and a 12-month high of $150.32.
Jacobs Solutions Dividend Announcement
Analyst Ratings Changes
Several research analysts recently issued reports on the stock. Credit Suisse Group decreased their price target on shares of Jacobs Solutions from $159.00 to $154.00 and set an “outperform” rating for the company in a research note on Tuesday, August 2nd. StockNews.com assumed coverage on shares of Jacobs Solutions in a research note on Wednesday, October 12th. They set a “buy” rating for the company. Royal Bank of Canada reduced their price objective on shares of Jacobs Solutions from $160.00 to $155.00 and set an “outperform” rating for the company in a research note on Thursday, August 4th. Finally, Citigroup reduced their price objective on shares of Jacobs Solutions from $155.00 to $151.00 and set a “buy” rating for the company in a research note on Tuesday, August 2nd. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Jacobs Solutions currently has a consensus rating of “Moderate Buy” and an average price target of $158.57.
Jacobs Solutions Company Profile
Jacobs Solutions Inc provides consulting, technical, scientific, and project delivery services for the government and private sectors in the United States, Europe, Canada, India, rest of Asia, Australia, New Zealand, South America, Mexico, the Middle East, and Africa. It provides cybersecurity, data analytics, systems and software application integration and consulting, enterprise and mission IT, engineering and design, nuclear, enterprise level operations and maintenance, artificial intelligence and automation, software development, digitally driven consulting, planning and architecture, program management, and other technical consulting solutions.
- Get a free copy of the StockNews.com research report on Jacobs Solutions (J)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn’t Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don’t Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
Receive News & Ratings for Jacobs Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jacobs Solutions and related companies with MarketBeat.com's FREE daily email newsletter.